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Tumor volume is a better predictor 
of post-operative wound complications 
compared to tumor size in soft tissue sarcomas 
of the proximal lower extremity
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Abstract 
Background: Wide local excision with or without radiation therapy (RT) and chemotherapy is widely accepted as 
appropriate management for soft tissue sarcomas (STS) of the extremity. Although survival and local control rates are 
comparable to amputation, post-operative wound complications (WC) following limb salvage can result in significant 
morbidity for the patient. Certain risk factors such as location, pre-operative RT, and age have been shown to increase 
the risk of WCs. Somewhat surprisingly, size has not consistently been shown to impact WC rates. The goal of this 
study is to assess whether tumor volume, as opposed to the traditional measurement of the largest dimension in one 
plane, correlates with the development of post-operative WCs.
Methods: Between 2000 and 2013, 81 patients with STS of the proximal lower extremity, buttock and pelvis were 
retrospectively identified from our prospective database. We reviewed the impact of patient, tumor, and treatment 
variables on postoperative WC. Predictors for WC were evaluated using the Fisher exact test for univariate analysis and 
logistic regression for multivariate analysis. Tumor volume was determined using the medical image merge (MIM) ® 
software program (version 6.5.4, MIM Software, Cleveland, OH). Tumor size (diameter) was determined the historical 
way of measuring the widest dimension on the sagittal, coronal, and axial planes from the MRI scan at midplane.
Results: The overall WC rate within 6 months of tumor resection was 32 %. WC were more likely to occur with larger 
tumor volumes (p = 0.015), although not with tumor diameters ≥10 cm (p = 0.55). Neither volume of subcutaneous 
fat (p = 0.34) or depth of the subcutaneous fat layer (p = 0.82) significantly impacted WC rates. Tumor proximity to 
skin surface also did not significantly impact WC risk (p = 0.73).
Conclusions: Increase in tumor volume led to a higher risk of post-operative WCs. Assessing tumor volume may 
allow clinicians to better counsel patients on their risk of post-operative WCs. Tumor volume, as opposed to size alone, 
should be considered in future sarcoma outcome studies.
© 2016 Ziegele et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Approximately 12,000 patients in the United States each 
year are diagnosed with soft tissue sarcomas (STS), rep-
resenting roughly 1  % of all adult malignancies [1]. In 
the past, due to concern for high local recurrence rates 
with local excision, amputation was routinely performed. 
However, there has been a transition in the management 
of STS of the extremity towards limb salvage resection in 
combination with radiation therapy (RT) with or without 
chemotherapy. This treatment approach has resulted in 
excellent local control rates [2, 3].
Despite advances in the treatment of STS, post-
operative wound complications (WC) following surgi-
cal resection of the tumor remain an important source 
of morbidity for patients. WC have been reported 
in 16–56  % of surgical cases [4, 5], and can include 
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complications such as seromas, hematomas, wound 
necrosis, wound dehiscence, cellulitis, and abscess 
formation.
Considerable research has been dedicated towards 
investigating risk factors for WC follow surgical resec-
tion of STS. Risk factors include, but are not limited to, 
location of disease, tumor size and proximity to skin, and 
timing of radiation. Tumor location is a strong predictive 
factor, with tumors located in the lower extremity (LE) 
experiencing higher rates of WC following surgery [6–
10]. Korah et  al. demonstrated that tumor location was 
the single most important risk factor for WC, and also 
reports a wound reoperation rate of 29 % for LE tumors 
vs. 4 % in upper extremity (UE) tumors [7].
Although location of the primary tumor has been 
consistently shown to impact the development of post-
operative WCs, this has not been the case for tumor 
size. Moreover, most studies that evaluate size as a risk 
factor take into consideration the maximal dimension 
of the primary tumor. While the maximal measurement 
in one dimension gives an idea of tumor size, the overall 
size, or volume, difference between a 3 ×  10  cm tumor 
and a 9 × 10 cm tumor is notable. There has been little 
information on the volume of the tumor and correlation 
to post-operative WCs.
Similar to tumor size, body mass index (BMI) and the 
amount of subcutaneous fat has not repeatedly been 
shown to influence WCs. This lack of consistency per-
haps demonstrates that more than one measurement var-
iable effects this outcome.
The objective of this study was to investigate addi-
tional variables that might impact post-operative WCs 
following surgical resection of STS. Specifically, utiliz-
ing a combination of volumetric and linear data gathered 
from preoperative MRIs, we determined if tumor vol-
ume and the ratio of subcutaneous (SC) fat, muscle and 
tumor impacted WC risk. To our knowledge the impact 
of SC fat on WC rates has never been investigated in 
STS, although high levels of SC fat have been linked with 
increased WC rates in other surgical procedures [11–13]. 
Additionally, the ability of tumor diameter to predict 
WC risk in comparison to tumor volume has never been 
investigated.
Methods
This research was reviewed and approved by the Institu-
tional Review Board (IRB) and all investigators completed 
training in both human research and patient privacy.
Patient population
All patients with localized primary STS of the proxi-
mal LE, buttock, and pelvis who underwent wide sur-
gical resection, with or without radiation, and/or 
chemotherapy between 2000 and 2013 were reviewed. 
Pelvic tumors in this study included sarcomas in the 
pelvis and buttock that were extra-peritoneal. No ret-
roperitoneal or peritoneal tumors were included in this 
study. Additional exclusion criteria included metastatic 
disease on initial presentation, age <18 years old, STS of 
locations other than the proximal LE, buttock, or pel-
vis, recurrent or non-oncologic resection of sarcomas 
at first presentation to our sarcoma center, and small 
subcutaneous tumors. All patients underwent resection. 
Patients who had radiation (preoperative or post-opera-
tive) or no radiation were included in the study. Patients 
who did not have complete medical records including 
treatment information and a pathology report, and fol-
low-up of less than 6  months were also excluded. His-
topathologic types demonstrating rhabdomyosarcoma, 
extraosseous primitive neuroectodermal tumor, Kaposi’s 
sarcoma, angiosarcoma, and desmoid fibromatosis were 
also excluded.
Eighty-one patients were identified in our database who 
met the inclusion criteria. Patients were staged accord-
ing to the 2009 American Joint Committee on Cancer 
(AJCC) system seventh edition.
Treatment
All patients were discussed at a multidisciplinary tumor 
board consisting of surgical and musculoskeletal oncolo-
gists, medical and radiation oncologists, radiologists and 
pathologists. Treatment recommendations from this 
tumor board were presented to the patient.
Radiotherapy and chemotherapy
Patients included in this study had either preoperative, 
post-operative or no RT. Those that had preoperative 
RT received a median dose of 50 Gy using 3D-conformal 
radiation or intensity-modulated radiotherapy (IMRT). 
Patients who received post-operative RT received a 
median dose of 60 Gy.
Chemotherapy was recommended and administered in 
patients who were typically <70  years of age, with large 
(>5  cm), deep, and high-grade lesions. Chemotherapy 
was a doxorubicin-ifosfamide based regimen given for 
1–3 cycles based on clinical response and tolerance.
Surgery
Limb-sparing resection was performed in all patients. 
Wide surgical resection was performed by fellowship 
trained musculoskeletal oncologists grossly through nor-
mal tissue planes with sacrifice of arteries or veins that 
were involved by tumor. Preservation of neurovascular 
structures was performed when possible. The goal of 
surgery was to achieve negative margins (R0). Vascular 
or reconstructive plastic surgeons were involved in cases 
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that required vascular reconstruction, difficult wound 
closures and free flap reconstructions.
Data collection
Pre-operative MRIs were downloaded into the medical 
image merge (MIM) ® software program (version 6.5.4, 
MIM Software, Cleveland, OH). MRI’s were acquired 
within 1  month prior to limb-sparing resection. Post-
operative MRI’s were also identified for linear meas-
urements from the incision to the deep fascia. Using 
axial views, tumors were identified and contoured from 
proximal to distal tip, generating data on maximal tumor 
diameter and tumor volume. Volumes of subcutaneous 
fat and lean mass (including muscle, bone, and blood ves-
sels) were gathered in a similar manner by contouring 
the structures from the proximal to distal boundaries of 
the tumor (Fig. 1). Tumor proximity to skin surface was 
measured from the point of maximal tumor diameter 
on the axial view to the future incision site determined 
from the patient’s post-operative MRI. Maximal subcuta-
neous fat layer depth was also measured in this manner, 
along the length of the tumor and directly adjacent to the 
future incision site.
Patient data, including age, sex, BMI, diabetic and 
smoking status, presence of cardiovascular disease, KPS 
score, tumor histology and stage/grade, use of flap recon-
struction, and treatment with chemotherapy were gath-
ered from the existing orthopedic oncology database of 
STS patients.
Outcomes
Post-operative WCs were defined as by the Canadian 
Multicenter Trial and were recorded if they occurred 
within 6 months following limb-salvage surgery (Table 1). 
In general, patients who required re-operation, pro-
longed wound care or antibiotics after resection were 
considered WC [10].
Statistical analysis
Statistical software MedCalc (Version 15.6; MedCalc 
Software bvba, Ostend, Belgium) was used for all data 
analysis. Clinical, pathologic and treatment character-
istics for WC were assessed and summarized in Table 2. 
Wound outcome was a dichotomous variable. The fisher 
exact test was used for univariate analysis (UVA). If a 
variable had a p value of less than 0.25, then it was used 
in the multivariate model. A logistic regression analysis 
was used for multivariate analysis (MVA). For all analy-
sis, type I error was maintained at 0.05 and all tests were 
two-sided.
A receiver operative characteristic (ROC) curve was 
constructed and used to examine whether the volumetric 
data could differentiate between tumors that were predis-
posed to post-operative WCs versus those that were not 
predisposed to post-operative WCs.
Results
Eighty-one patients with stage I–III STS of the LE and 
buttock underwent treatment at this institution and 
were eligible for the study. Sixty-nine (85  %) patients 
had tumors located in the proximal LE, eight (10 %) had 
tumors in the buttock, and four (5 %) had tumors located 
in the pelvic region. An overview of patient, tumor, and 
treatment characteristics can be found in Table 2. Median 
age at diagnosis was 57 (range: 26–84), and median fol-
low-up was 1.7  years. All 81 patients underwent limb-
salvage resection; no patient underwent an amputation at 
the time of definitive resection.
The overall WC rate within 6 months of tumor resec-
tion and as defined by the Canadian Multicenter Trial 
[10], was 32  % (26 of 81 patients). Of these, ten (38  %) 
patients developed wound dehiscence and necrotic 
wounds, ten (38  %) patients developed infection, five 
(20 %) patients had delayed wound healing, and one (4 %) 
patient developed a post-operative hematoma. Fifty-
four (67  %) patients had high grade tumors, four (5  %) 
intermediate grade, and 23 (28 %) low grade. There was 




Fig. 1 Forty-eight year old with a high grade myxofibrosarcoma of 
the proximal thigh. Axial (A), coronal (B) and sagittal (C) views with 
contours of fat (blue), muscle (red) and tumor (purple)
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high grade (29.7  %) vs. low/intermediate grade (37.0  %) 
tumors (p = 0.61).
Median BMI of patients in our study was 28.8. WC 
occurred in 15 patients (37.5  %) with a BMI >28.8, and 
in eleven patients (28.2  %) with a BMI <28.8; this dif-
ference was not significant on UVA (p =  0.47) or MVA 
(p =  0.18). Similarly, when BMI was analyzed as a con-
tinuous variable, it did not significantly impact WC rates 
(OR 1.0448, 95 % CI 0.9746–1.1201, p = 0.22).
Forty-three patients had a tumor diameter of ≥10 cm. 
The WC rate was 39.5 % with tumors that were >10 cm 
compared to 23.6  % when the primary tumor meas-
ured <10 cm. This failed to reach statistical significance 
(p = 0.15). Increasing tumor volume, however, was asso-
ciated with higher WC rates. The median tumor volume 
of patients in this study was 228.1 mL. WC occurred in 
17/41 (41.5 %) patients with a tumor volume ≥228.1 mL, 
and in 9/40 (22.5  %) patients with a tumor volume 
<228.13  mL; p  =  0.015). Increasing tumor volume was 
also significant when assessing this measure as a con-
tinuous variable (p = 0.015, OR 1.0010, 95 % CI 1.0001–
1.0018). This finding held on MVA (p = 0.03, OR 1.0010, 
95 % CI 1.0001–1.0018). A scatter plot depicting tumor 
size versus volume is located in Fig. 1.
The volume of subcutaneous fat did not significantly 
impact WC rates in this study (p = 0.34, OR 1.0002, CI 
0.9998–1.0005). In addition, ratios comparing volumes 
of lean mass to subcutaneous fat (p =  0.69, OR 0.8683, 
95 % CI 0.4306–1.7507) and volumes of subcutaneous fat 
to tumor (p = 0.55, OR 0.9822, 95 % CI 0.9257–1.0421) 
failed to reveal a significant relationship to WC on logis-
tic regression. Depth of the subcutaneous fat layer at the 
incision site likewise did not impact WC rates.
Seventy (86  %) patients underwent preoperative RT, 
three (4  %) patients underwent postoperative RT, and 
eight (10  %) patients received both pre- and postop-
erative RT. There were no significant differences in WC 
rates between these groups. Fifty-six (69  %) patients 
received neoadjuvant chemotherapy, which had no sig-
nificant impact on WC rates upon UVA (35.7 vs. 31.6 %, 
p = 0.44). No patient included in our study received adju-
vant chemotherapy.
Primary closure was utilized for 50 (62  %) patients, 
while 31 (38 %) patients were selected for a vascularized 
flap closure with plastic surgery. Use of the flap closure 
was associated with higher WC rates (45 %) than primary 
closure (26 %), a difference which was significant on MVA 
(OR 3.6969, 95 % CI 1.2432–10.9938, p = 0.02). No other 
variables were significant on UVA or MVA (Table 3).
Local control in this cohort was 100  % and the dis-
tant metastasis rate was 30.8 %. Median survival was not 
met, but 2-year overall survival was 93.4 %. Median and 
2-year progression-free survival was 66 months and 65 %, 
respectively. Similarly, median and 2-year distant metas-
tasis-free survival was 66 months and 65 %, respectively.
Discussion
While pre-operative RT combined with wide surgical 
resection of STS improves disease free survival and has 
become the standard in limb salvage care at many institu-
tions, post-operative WCs remain a considerable source 
of morbidity for patients. Several studies have investi-
gated variables that influence post-operative WCs, which 
include, but are not limited to tumor size and location, 
proximity to skin surface, radiation field size, and timing 
of radiation [4, 14–16].
Location of the primary tumor has consistently been 
shown to impact post-operative WCs. Moore et  al. 
reports a 23  % difference in WC rate for proximal LE 
tumors and proximal UE tumors [6]. Tumors in the 
adductor compartment of the proximal thigh are particu-
larly prone to WC, a trend likely explained by disruption 
of the lymphatic network of the LE which occurs during 
surgery [6]. For this study, we wanted to eliminate the 
Table 1 Canadian multicenter wound complication definition
Wound complication category Definition
Surgical complications Secondary operations required for wound treatment 
(debridement, secondary closure procedures such as 
rotationplasty, free flaps, or skin grafts)
Invasive procedure required for wound care (drainage of 
hematoma, seroma, or infected wound collection)
Deep wound packing required at any time (deep pack-
ing defined as packing deep to dermis in an area of 
dehisced wound) to an area of the wound measuring 
≥2 cm in length
Non-surgical complications Readmission to hospital for wound care
Prolonged dressing changes, including packing of the 
wound for >6 weeks from wound break down
Failure of epithelialization of skin graft by 4 weeks after 
surgery
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confounding influence of tumor location on WC risk. 
Therefore, our cohort only included patients with tumors 
in the proximal LE, buttock, or pelvic area.
Tumor size is a strong predictor of WC risk, a relation-
ship which is demonstrated by multiple studies [4, 6, 7, 
10, 17]. Tumors greater than 10 cm [4, 6, 10], 8 cm [7], 
and even 5 cm in diameter [18] have all been shown to be 
associated with higher WC risk. A probable explanation 
for the impact of tumor size on WC rates is that larger 
tumors generate a greater dead-space in the soft tissue 
following resection, predisposing the patient to seromas, 
hematomas, and infection. Our study did not demon-
strate that tumors greater than 10  cm in diameter were 
associated with a statistically significant higher risk of 
WCs. We did however find a statistically significant rela-
tionship between tumor volume and WC rate, establish-
ing that increasing tumor volume predicts a greater risk 
of postoperative WC. This finding first corroborates prior 
research on the importance of tumor size as a risk fac-
tor for postoperative WC. More notably however, it also 
suggests that tumor volume, rather than tumor diameter 
or cross-sectional area, is a more powerful predictor of 
postoperative WC risk. Moreover, as conveyed in Fig. 2, 






 F 30 (37 %)
 M 51 (63 %)
Performance status (KPS)
 81–100 71(88 %)
 ≤80 10 (12 %)
Cardiovascular disease
 No 74 (91 %)
 Yes 7 (9 %)
Diabetes
 No 72 (89 %)
 Yes 9 (11 %)
Smoking history
 No 57 (70 %)
 Yes 24 (30 %)
Stage
 I 20 (25 %)
 II 10 (12 %)
 III 51 (63 %)
Size
 <10 cm 38 (47 %)
 ≥10 cm 43 (53 %)
Location
 Proximal lower extremity 69 (85 %)
 Buttock 8 (10 %)
 Hip/pelvis 4 (5 %)
Grade
 Low 23 (28 %)
 Intermediate 4 (5 %)
 High 54 (67 %)
Histology
 Undifferentiated 10 (12 %)
 Liposarcoma/leiomyosarcoma 31 (38 %)
 Myxofibrosarcoma 11 (14 %)
 Synovial 4 (5 %)
 Spindle cell 13 (16 %)
 Other 12(15 %)
Neoadjuvant chemotherapy
 No 25 (31 %)
 Yes 56 (69 %)
Timing of RT
 No RT 8 (10 %)
 Preoperative RT 70 (86 %)
 Post-operative RT 3 (4 %)
Flap reconstruction
 No 50 (62 %)
 Yes 31(38 %)
Table 3 UVA of WC variables
Variable p value
BMI (>28/<28) 0.474
Neoadjuvant chemo (Y/N) 0.440
Cardiovascular disease (Y/N) 0.675
Diabetes (Y/N) 0.458
Smoking (Y/N) 0.798
Grade (high grade/non-high grade) 0.615
KPS score (>80/≤80) 0.278
Sex (M/F) 0.474
Tumor size (≥10 cm/<10 cm) 0.156




















Fig. 2 Tumor size vs. tumor volume scatter plot
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Fig. 3 a Patient A and B’s Tumor size and corresponding volume on axial view. b Patient A and B’s tumor size and corresponding volume on sagittal 
view. c Patient A and B’s tumor size and corresponding volume on coronal view
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there seems to be little relationship between size and vol-
ume, most likely because STS are often not spherical, but 
have an irregular shape. Thus, as mentioned above, maxi-
mal dimension may only provide one component influ-
encing WC, and it is truly the volume that impacts this 
outcome. By measuring a 3-dimensional tumor in only 
one plane it is easy to over or under estimate true tumor 
burden, thereby misjudging the soft-tissue defect which 
will be left post-resection along with the associated WC 
risk (Fig. 3a–c). Work by Geller et al. has previously dem-
onstrated that tumor volume is associated with WC risk 
[5]. In this study however, tumor volume was measured 
from final gross pathology specimens and was also not 
compared to tumor diameter or cross sectional area. To 
our knowledge, our study is the first to assess if tumor 
volumes contoured from preoperative MRIs predict post-
operative WC risk. It also for the first time demonstrates 
that volumetric measurements may be more representa-
tive of tumor size than measuring tumor diameter, a find-
ing which has implications for predicting WC risk, as well 
as potentially other treatment outcomes, preoperatively.
With the expanding obesity epidemic in the United 
States, the impact of subcutaneous fat on WC risk is 
a crucial area of investigation in STS. BMI has failed to 
demonstrate a significant association with WCs in prior 
studies [6], as well as our own. However, BMI fails to 
take into account factors such as gender differences in 
adipose tissue distribution and also levels of lean muscle 
mass which may weaken any association with WC risk. 
Levels of subcutaneous fat tissue surrounding the inci-
sion site has yet to be investigated in STS, although it has 
been demonstrated to impact WC rates in other arenas 
of surgery. In one study of cervical spine fusions, patients 
with subcutaneous fat layer depths of >40  mm were at 
significantly higher risk of surgical site infection (18.2 %) 
than patients with thinner layers of <20 mm (5.2 %) and 
<10  mm (2.3  %) [17]. Similar results have been pub-
lished in gynecologic and general surgery, indicating 
that the thickness of SC fat surrounding the incision site 
impacts WC risk [11–13, 19, 20]. Increased SC fat thick-
ness necessitates a longer surgical incision, as well as 
increased retraction which may lead to tissue necrosis 
at the operative site. A thicker subcutaneous layer also 
increases wound tension at closure, placing the patient 
at increased risk for wound dehiscence and also reduc-
ing tissue microperfusion and oxygen availability to the 
wound [21]. In contrast to the aforementioned research, 
our study did not demonstrate a significant relationship 
between WC risk and either subcutaneous fat volume or 
depth of the adipose layer adjacent to the incision. One 
limitation to our study which may have impacted results 
is that a nine of the preoperative MRIs had small sec-
tions of peripheral tissue cut off, not allowing us to fully 
contour fat and muscle layers. Additionally, our measure-
ment of subcutaneous fat volume included adipose tissue 
from the entire circumference of the leg, not just sur-
rounding the incision site. An avenue for future research 
may be measurement of the SC fat volume surrounding 
only the leg compartment specific to the tumors location.
Reconstruction of surgical wounds with vascularized 
flaps is utilized as an alternative to primary closure fol-
lowing resection of STS. It is intended to lower WC risk 
through minimizing residual dead space and also substi-
tuting previously irradiated soft tissues with healthy and 
well-vascularized tissue from a donor site. The literature 
returns mixed results on the impact of plastic recon-
struction on WC risk; some studies conclude that it low-
ers risk [22], others find that it increases it [4], while yet 
others demonstrate no impact [6]. Analysis of our patient 
cohort indicates that reconstruction with vascularized 
flaps was a statistically significant risk factor for WC. It 
should be noted however that there is likely a strong ele-
ment of selection bias in this finding. Patients selected 
for immediate flap reconstruction at our institution were 
often those felt to be at higher risk for postoperative WC. 
These included patients with greater tumor volumes, vas-
cular involvement of their tumor, and host comorbidities 
which may have increased their risk for WCs.
The association between preoperative RT and increased 
WC risk has been well established. O’Sullivan et  al. 
reported an 18 % increase in WC rate with preoperative 
RT in comparison to postoperative RT, a finding which 
has been replicated by additional studies [6, 23]. Tim-
ing of RT was not a significant risk factor for WC in our 
study; however this is not surprising as the vast major-
ity of our patients underwent preoperative RT. Similarly, 
the administration of neoadjuvant chemotherapy did not 
predispose patients to WC in our study. This is a finding 
which is consistent with other published work.
Baldini et  al. describes that tumor proximity to skin 
surface impacts WC risk, reporting that tumors located 
<3 mm from the skin surface increase risk for WC (OR 
3.9) [4]. This finding however has not been replicated in 
additional research [6], and is also not shown in our find-
ings. Timing of radiotherapy in our study may be a factor 
in this negative result. Baldini et al. suggests that preop-
erative RT of superficial tumors delivers an unavoidably 
high radiation dose to the surgical flaps used in wound 
closure, increasing the risk for WC. While the majority 
of patients in our study received preoperative RT (86 %), 
some did undergo postoperative RT or no RT at all, 
which may have impacted results. Another possibility is 
that our small sample size limited our ability to find a sig-
nificant relationship.
One weakness of our study was our small sample size. 
STS are exceedingly rare cancers, and by restricting our 
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study population to only patients with tumors in the 
proximal LE, buttock, or pelvis, we limited our sam-
ple size. This could potentially explain why some of our 
results did not reach the level of statistical significance. 
For instance, prior research has demonstrated diabetes 
to be powerful risk factor for WC following resection of 
STS [4, 6]. In our study there were large differences in 
WC risk for patients with diabetes (44.4 vs. 30.6 %). This 
difference was not significant however, which may be due 
to our analysis being underpowered. Additional limita-
tions to our study include the retrospective nature of 
the study and the inherent biases which come with this 
design, as well as the limited field of view on nine of the 
preoperative MRIs which limited our ability to accurately 
contour structures. Another limitation of the study is the 
potential error in the volume measurements. Contour-
ing structures on MRI scans is a very operator depend-
ent process, and results may vary from person to person 
based on contouring technique. We attempted to limit 
the potential impact of this by having all measurements 
acquired by a single researcher. Although all data was 
generated by a single researcher in our study, the intra 
and inter-observer variability associated with the volume 
measurement technique is unknown and attempts to 
replicate this research in the future may be prone to this 
bias.
Conclusions
In this study, it was tumor volume, more than size that 
impacted the development of post-operative WCs. Our 
study demonstrates that gathering data on tumor vol-
ume, rather than diameter, may be a more accurate 
means of predicting WC risk. Tumor volume measure-
ments could allow clinicians to more accurately counsel 
patients regarding their risk of WCs and also arrange for 
more aggressive follow-up and prophylactic regimens 
to combat the risk of WC. Further investigations on the 
relationship between volumetric parameters and treat-
ment outcomes are warranted.
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